Abstract
Thyroid carcinoma arising from normal follicular cells is generally slow-growing with an excellent prognosis if competently resected. However, once the tumor dedifferentiates and becomes undifferentiated (anaplastic) carcinoma, it becomes one of the most aggressive malignancies. Such a polarized characteristic is quite unique yet typical of thyroid carcinoma. To date, many researchers have studied differences in the characteristics of thyroid carcinoma before and after dedifferentiation. In this review, the difference in cell proliferating activity and the expression of cell cycle modulators is addressed. Cell proliferating activity of undifferentiated carcinoma is definitely higher than that of differentiated carcinoma. However, expression of cell cycle modulators in thyroid carcinoma is often unique and even discrepant. Some negative modulators are diffusely expressed and reduced expression of some positive modulators can be observed in undifferentiated carcinoma. We described these interesting findings in thyroid carcinoma in this review.
Keywords: thyroid cancer, cell cycle, cell proliferation
Current Cancer Therapy Reviews
Title: Expression of Cell Cycle Regulators in Thyroid Neoplasms Originating from Follicular Cells
Volume: 1 Issue: 2
Author(s): Yasuhiro Ito
Affiliation:
Keywords: thyroid cancer, cell cycle, cell proliferation
Abstract: Thyroid carcinoma arising from normal follicular cells is generally slow-growing with an excellent prognosis if competently resected. However, once the tumor dedifferentiates and becomes undifferentiated (anaplastic) carcinoma, it becomes one of the most aggressive malignancies. Such a polarized characteristic is quite unique yet typical of thyroid carcinoma. To date, many researchers have studied differences in the characteristics of thyroid carcinoma before and after dedifferentiation. In this review, the difference in cell proliferating activity and the expression of cell cycle modulators is addressed. Cell proliferating activity of undifferentiated carcinoma is definitely higher than that of differentiated carcinoma. However, expression of cell cycle modulators in thyroid carcinoma is often unique and even discrepant. Some negative modulators are diffusely expressed and reduced expression of some positive modulators can be observed in undifferentiated carcinoma. We described these interesting findings in thyroid carcinoma in this review.
Export Options
About this article
Cite this article as:
Ito Yasuhiro, Expression of Cell Cycle Regulators in Thyroid Neoplasms Originating from Follicular Cells, Current Cancer Therapy Reviews 2005; 1 (2) . https://dx.doi.org/10.2174/1573394054021736
DOI https://dx.doi.org/10.2174/1573394054021736 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Related Books

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Diagnostic Capabilities of MRI Versus 18F FDG PET-CT in Postoperative Patients with Thyroglobulin Positive, 131I-negative Local Recurrent or Metastatic Thyroid Cancer
Current Medical Imaging T Cell Homeostasis in Centenarians: From the Thymus to the Periphery
Current Pharmaceutical Design Chronopharmaceutical Delivery of Anti-Inflammatory Drugs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Gallium-68 in Medical Imaging
Current Radiopharmaceuticals Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis
Current Pharmaceutical Design CFTR Chloride Channel Drug Discovery - Inhibitors as Antidiarrheals and Activators for Therapy of Cystic Fibrosis
Current Pharmaceutical Design Vertebrate Protein CTCF and its Multiple Roles in a Large-Scale Regulation of Genome Activity
Current Genomics The Impact of Traditional Chinese Medicine on Mitophagy in Disease Models
Current Pharmaceutical Design Current Protein-based Anti-angiogenic Therapeutics
Mini-Reviews in Medicinal Chemistry The Human L1 Element: A Potential Biomarker in Cancer Prognosis, Current Status and Future Directions
Current Molecular Medicine Molecular Targets and Angiogenesis in Renal Cell Carcinoma, A Multitarget Approach: Mini Review
Current Drug Targets Neonatal Germ Cell Tumors
Current Pediatric Reviews Current Advances in the Development of Anticancer Drugs Targeting Tyrosine Kinases of the Src Family
Current Drug Therapy Phytoestrogens and Prostate Cancer
Current Drug Targets Emerging Anabolic Treatments in Osteoporosis
Current Drug Safety An Insight into Anticancer Bioactives from <i>Punica granatum</i> (Pomegranate)
Anti-Cancer Agents in Medicinal Chemistry Cardiac Dys-Synchronization and Arrhythmia in Hyperhomocysteinemia
Current Neurovascular Research MicroRNAs: Crucial Players in the Differentiation of Human Pluripotent and Multipotent Stem Cells into Functional Hepatocyte-Like Cells
Current Stem Cell Research & Therapy Xanthohumol: A Metabolite with Promising Anti-Neoplastic Potential
Anti-Cancer Agents in Medicinal Chemistry Biomarkers of Oxidative Stress and the Relationship to Cigarette Smoking
Mini-Reviews in Organic Chemistry